Evidence map›Paper›PMID 40259584›Full record

ReviewCurrent organic synthesis2025

Advances in the Total Synthesis of Pharmacologically Important Fused Indolizidine Alkaloids: Securinine, Gephyrotoxin and Lepadiformine.

Afiqah A A Ali, Agustono Wibowo, Nor H M Rosli, Jhi B Foo, Mohd F Mohammat, Jason S E Loo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current organic synthesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Afiqah A A AliSchool of Pharmacy, Faculty of Health & Medical Sciences, Taylor's University, No. 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia.
Agustono WibowoFaculty of Applied Science, Universiti Teknologi MARA (UiTM) Pahang, Jengka Campus, 26400, Bandar Tun Abdul Razak Jengka, Pahang, Malaysia.
Nor H M RosliFaculty of Applied Science, Universiti Teknologi MARA (UiTM) Pahang, Jengka Campus, 26400, Bandar Tun Abdul Razak Jengka, Pahang, Malaysia.
Jhi B FooSchool of Pharmacy, Faculty of Health & Medical Sciences, Taylor's University, No. 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia.
Mohd F MohammatOrganic Synthesis Laboratory, In-stitute of Science, Universiti Teknologi MARA (UiTM), 40450, Shah Alam, Selangor, Malaysia.
Jason S E LooSchool of Pharmacy, Faculty of Health & Medical Sciences, Taylor's University, No. 1, Jalan Taylors, 47500, Subang Jaya, Selangor, Malaysia.ORCID 0000-0001-6976-3282

Funding

Ministry of Higher Education (MOHE), Malaysia under Fundamental Research Grant Scheme (FRGS) FRGS/1/2021/SKK0/TAYLOR/02/1
6 · The paper itself

Abstract

Indolizidine alkaloids represent a diverse group of naturally occurring compounds which are derived from various sources and possess a wide range of pharmacological activities. Fused indolizidine alkaloids represent a distinct subset of these compounds, where additional rings are fused with the indolizidine core. When combined with the specific stereochemistry typically required for their biological activity, the fused ring structure complicates the synthesis of this important class of compounds. Among the well-studied fused indolizidine alkaloids are securinine, gephyrotoxin, and lepadiformine, which have all exhibited potential in important therapeutic areas. Due to their complex structures, over the years numerous approaches have been proposed to synthesize these compounds. In this article, we review the progress made in synthetic routes for these key fused indolizidine alkaloids throughout history, providing a broad overview and the distinct advantages of the various strategies that could be employed in their synthesis.

Indexed as

AlkaloidsHeterocyclic Compounds, Bridged-RingIndolizidinesIndolizinesLactonesAzepinesMolecular StructurePiperidinesAlkaloidsAzepinesHeterocyclic Compounds, Bridged-RingIndolizidinesIndolizinesLactonesPiperidinessecurininegephyrotoxinindolizidine alkaloidslepadiforminesecurininestereochemistry.Synthesis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.